S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 126 SEK -2.25% Market Closed
Market Cap: 6.4B SEK

Surgical Science Sweden AB
Investor Relations

Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2017-06-19. The systems comprise LapSim, EndoSim and TeamSim trainings. Each training combine graphics and cognitive instruction, imply navigation on touch screens and feature tactile feedback technology. The LapSim trainings consist of laparoscopic exercises that range from basic navigation to advanced suturing, the EndoSim endoscopic exercises range from functions of the scope handle and tube, to loop reduction. The TeamSim comprises procedure modules to train in a real world operation room environment and helps to build team communication skills in crisis and routine situations. The training systems are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors.

Show more
Loading

Earnings Calls

2024 Q4
Feb 13, 2025
Show Transcript
Previous
Next
Wilhelmsen Group Reports Strong Performance with Dividend Growth
2024 Q4
Feb 13, 2025

The Wilhelmsen Group reported robust performance driven by its subsidiary Wallenius Wilhelmsen, yielding an $171 million dividend for the quarter and a total of $282 million for the year. This resulted in an 18% return for shareholders. The company announced financial health with a 72% equity ratio and ongoing contract renegotiations enhancing business strength. Earnings before interest, taxes, depreciation, and amortization (EBITDA) experienced an 11% year-over-year rise, reaching $16 million. Management forecasts a first dividend of NOK 12 per share with a potential total of NOK 20, underscoring continued commitment to shareholder value amidst strategic growth initiatives.

Show Full Analysis

Management

Mr. Gisli Hennermark
Advisor & Director
No Bio Available
Mr. Tom Englund
Chief Executive Officer
No Bio Available
Mr. Anders Larsson
Co-Founder & CTO
No Bio Available
Ms. Anna Ahlberg
Chief Financial Officer
No Bio Available
Mr. Boaz Tal ), Adv. (CPA, C.P.A.
Chief Operating Officer
No Bio Available
Mr. Martin Jansson
Head of Global Sales
No Bio Available
Ms. Inbal Mazor-Badichi
Executive Vice President of Products & Marketing
No Bio Available
Mr. Daniel Evestedt
Head of Development
No Bio Available
Mr. Jeffrey Berkley Ph.D.
Chief Innovation Officer
No Bio Available
Mr. Ran Bronstein
President of Research & Development
No Bio Available

Contacts

Address
VASTRA GOTALANDS
Goeteborg
Drakegatan 7 A, 3 tr.
Contacts
+46317416560.0
surgicalscience.com